|
1
|
Lynch TJ, Bell DW, Sordella R,
Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat
SM, Supko JG, Haluska FG, et al: Activating mutations in the
epidermal growth factor receptor underlying responsiveness of
non-small-cell lung cancer to gefitinib. N Engl J Med.
350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Paez JG, Jänne PA, Lee JC, et al: EGFR
mutations in lung cancer: correlation with clinical response to
gefitinib therapy. Science. 304:1497–1500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pao W, Miller V, Zakowski M, Doherty J,
Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, et al:
EGF receptor gene mutations are common in lung cancers from ‘never
smokers’ and are associated with sensitivity of tumors to gefitinib
and erlotinib. Proc Natl Acad Sci USA. 101:13306–13311. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mok TS, Wu YL, Thongprasert S, Yang CH,
Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ichinose Y, et
al: Gefitinib or carboplatin-paclitaxel in pulmonary
adenocarcinoma. N Engl J Med. 361:947–957. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pao W, Wang TY, Riely GJ, Miller VA, Pan
Q, Ladanyi M, Zakowski MF, Heelan RT, Kris MG and Varmus HE: KRAS
mutations and primary resistance of lung adenocarcinomas to
gefitinib or erlotinib. PLoS Med. 2:e172005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shaw AT, Kim DW, Nakagawa K, Seto T, Crinó
L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, et al:
Crizotinib versus chemotherapy in advanced ALK-positive lung
cancer. N Engl J Med. 368:2385–2394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
National Institute for Health and Care
Excellence: Erlotinib for the first-line treatment of locally
advanced or metastatic EGFR-TK mutation-positive non-small cell
lung cancer. http://publications.nice.org.uk/erlotinib-for-the-first-line-treatment-of-locally-advanced-or-metastatic-egfr-tk-mutation-positive-ta258Accessed.
November 04–2013
|
|
8
|
National Institute for Health and Care
Excellence: Crizotinib for previously treated non-small-cell lung
cancer associated with an anaplastic lymphoma kinase fusion gene.
http://www.nice.org.uk/guidance/TA296Accessed.
August 29–2014
|
|
9
|
Medford AR, Bennett JA, Free CM and
Agrawal S: Mediastinal staging procedures in lung cancer: EBUS,
TBNA and mediastinoscopy. Curr Opin Pulm Med. 15:334–342. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Medford AR, Bennett JA, Free CM and
Agrawal S: Endobronchial ultrasound-guided transbronchial needle
aspiration (EBUS-TBNA): applications in chest disease. Respirology.
15:71–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Santis G, Angell R, Nickless G, Quinn A,
Herbert A, Cane P, Spicer J, Breen R, McLean E and Tobal K:
Screening for EGFR and KRAS mutations in endobronchial ultrasound
derived transbronchial needle aspirates in non-small cell lung
cancer using COLD-PCR. PLoS One. 6:e251912011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia-Olivé I, Monsó E, Andreo F,
Sanz-Santos J, Taron M, Molina-Vila MA, Llatjós M, Castellà E,
Moran T, Bertran-Alamillo J, et al: Endobronchial ultrasound-guided
transbronchial needle aspiration for identifying EGFR mutations.
Eur Respir J. 35:391–395. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakajima T, Yasufuku K, Suzuki M,
Hiroshima K, Kubo R, Mohammed S, Miyagi Y, Matsukuma S, Sekine Y
and Fujisawa T: Assessment of epidermal growth factor receptor
mutation by endobronchial ultrasound-guided transbronchial needle
aspiration. Chest. 132:597–602. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakajima T, Yasufuku K, Nakagawara A,
Kimura H and Yoshino I: Multigene mutation analysis of metastatic
lymph nodes in non-small cell lung cancer diagnosed by
endobronchial ultrasound-guided transbronchial needle aspiration.
Chest. 140:1319–1324. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schuurbiers OC, Looijen-Salamon MG,
Ligtenberg MJ and van der Heijden HF: A brief retrospective report
on the feasibility of epidermal growth factor receptor and KRAS
mutation analysis in transesophageal ultrasound- and endobronchial
ultrasound-guided fine needle cytological aspirates. J Thorac
Oncol. 5:1664–1667. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Folch E, Yamaguchi N, VanderLaan PA,
Kocher ON, Boucher DH, Goldstein MA, Huberman MS, Kent MS,
Gangadharan SP, Costa DB, et al: Adequacy of lymph node
transbronchial needle aspirates using convex probe endobronchial
ultrasound for multiple tumor genotyping techniques in
non-small-cell lung cancer. J Thorac Oncol. 8:1438–1444. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boulanger S, Delattre C, Descarpentries C,
Escande F, Bouchindhomme B, Copin MC, Dhalluin X, Scherpereel A,
Ramon PP, Cortot A, et al: Feasibility of assessing EGFR mutation
and others using samples obtained by EBUS transbronchial needle
aspiration. Rev Mal Respir. 30:351–356. 2013.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Esterbrook G, Anathhanam S and Plant PK:
Adequacy of endobronchial ultrasound transbronchial needle
aspiration samples in the subtyping of non-small cell lung cancer.
Lung Cancer. 80:30–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Navani N, Brown JM, Nankivell M, Woolhouse
I, Harrison RN, Jeebun V, Munavvar M, Ng BJ, Rassl DM, Falzon M, et
al: Suitability of endobronchial ultrasound-guided transbronchial
needle aspiration specimens for subtyping and genotyping of
non-small cell lung cancer: a multicenter study of 774 patients. Am
J Respir Crit Care Med. 185:1316–1322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Billah S, Stewart J, Staerkel G, Chen S,
Gong Y and Guo M: EGFR and KRAS mutations in lung carcinoma:
molecular testing by using cytology specimens. Cancer Cytopathol.
119:111–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jurado J, Saqi A, Maxfield R, Newmark A,
Lavelle M, Bacchetta M, Gorenstein L, Dovidio F, Ginsburg ME,
Sonett J, et al: The efficacy of EBUS-guided transbronchial needle
aspiration for molecular testing in lung adenocarcinoma. Ann Thorac
Surg. 96:1196–1202. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yung RC, Otell S, Illei P, Clark DP,
Feller-Kopman D, Yarmus L, Askin F, Gabrielson E and Li QK:
Improvement of cellularity on cell block preparations using the
so-called tissue coagulum clot method during endobronchial
ultrasound-guided transbronchial fine-needle aspiration. Cancer
Cytopathol. 120:185–195. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmid-Bindert G, Wang Y, Jiang H, Sun H,
Henzler T, Wang H, Pilz LR, Ren S and Zhou C: EBUS-TBNA provides
highest RNA yield for multiple biomarker testing from routinely
obtained small biopsies in non-small cell lung cancer patients - a
comparative study of three different minimal invasive sampling
methods. PLoS One. 8:e779482013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang YR, Park HY, Jeon K, Koh WJ, Suh GY,
Chung MP, Kim H, Kwon OJ, Choi YL, Han J, et al: EGFR and KRAS
mutation analyses from specimens obtained by bronchoscopy and
EBUS-TBNA. Thorac Cancer. 4:264–272. 2013. View Article : Google Scholar
|
|
26
|
Medford AR, Agrawal S, Free CM and Bennett
JA: A performance and theoretical cost analysis of endobronchial
ultrasound-guided transbronchial needle aspiration in a UK tertiary
respiratory centre. QJM. 102:859–864. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeyabalan A, Shelley-Fraser G and Medford
AR: Impact of needle gauge on characterization of endobronchial
ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)
histology samples. Respirology. 19:735–739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Medford AR and Pillai A: Cytotechnician
rapid on-site evaluation for cytology for transbronchial needle
aspiration. J Bronchology Interv Pulmonol. 20:189–190. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Travis WDI, Brambilla E, Noguchi M,
Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ,
Van Schil PE, et al: International Association for the Study of
Lung Cancer/American Thoracic Society/European Respiratory Society
international multidisciplinary classification of lung
adenocarcinoma. J Thorac Oncol. 6:244–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kaufmann O, Fietze E, Mengs J and Dietel
M: Value of p63 and cytokeratin 5/6 as immunohistochemical markers
for the differential diagnosis of poorly differentiated and
undifferentiated carcinomas. Am J Clin Pathol. 116:823–830. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khayyata S, Yun S, Pasha T, Jian B,
McGrath C, Yu G, Gupta P and Baloch Z: Value of P63 and CK5/6 in
distinguishing squamous cell carcinoma from adenocarcinoma in lung
fine-needle aspiration specimens. Diagn Cytopathol. 37:178–183.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yatabe Y, Mitsudomi T and Takahashi T:
TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol.
26:767–773. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stenhouse G, Fyfe N, King G, Chapman A and
Kerr KM: Thyroid transcription factor 1 in pulmonary
adenocarcinoma. J Clin Pathol. 57:383–387. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shi Y, Au JS, Thongprasert S, Srinivasan
S, Tsai CM, Khoa MT, Heeroma K, Itoh Y, Cornelio G and Yang PC: A
prospective, molecular epidemiology study of EGFR mutations in
Asian patients with advanced non-small-cell lung cancer of
adenocarcinoma histology (PIONEER). J Thorac Oncol. 9:154–162.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Diacon AH, Schuurmans MM, Theron J,
Brundyn K, Louw M, Wright CA and Bolliger CT: Transbronchial needle
aspirates: How many passes per target site? Eur Respir J.
29:112–116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yatabe Y, Matsuo K and Mitsudomi T:
Heterogeneous distribution of EGFR mutations is extremely rare in
lung adenocarcinoma. J Clin Oncol. 29:2972–2977. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kosaka T, Yatabe Y, Endoh H, Kuwano H,
Takahashi T and Mitsudomi T: Mutations of the epidermal growth
factor receptor gene in lung cancer: Biological and clinical
implications. Cancer Res. 64:8919–8923. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
National Comprehensive Cancer Network:
NCCN guidelines for patients. http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdfAccessed.
March 20–2014
|
|
39
|
Jeyabalan A and Medford AR: Endobronchial
ultrasound-guided transbronchial needle aspiration, patient
satisfaction under light conscious sedation. Respiration.
88:244–250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sakairi Y, Nakajima T, Yasufuku K, Ikebe
D, Kageyama H, Soda M, Takeuchi K, Itami M, Iizasa T, Yoshino I, et
al: EML4-ALK fusion gene assessment using metastatic lymph node
samples obtained by endobronchial ultrasound-guided transbronchial
needle aspiration. Clin CancerRes. 16:4938–4945. 2010. View Article : Google Scholar
|
